Expression of CIRBP is upregulated in murine models of hepatocarcinogenesis as well as in liver tissues from HCC patients, where it promotes tumour development by expanding cancer stem/progenitor cell populations through a mechanism involving increased reactive oxygen species and activation of STAT3 signalling. Here, CIRBP is linked to hepatocellular carcinoma.